Talecris links

• Talecris Global
• Career Opportunities

• General Conditions of Use
• Privacy Statement
• Imprint

Program Focus

All Letters of Intent submitted to the Talents Program will be reviewed closely by the Talents Evaluation Committee. However, those that are most closely aligned with the goals of the program stand the best chance of receiving funding. Generally speaking, the Talents Program is looking for proposals that address the use of IGIV in immunological, hematological, and neurological indications.

Such proposals may include, but are not limited to, efficacy, mechanism of action, safety and tolerability, quality of life, pharmacoeconomics, and route of administration.

Talecris is also interested in supporting research into other uses of IGIV and has funded investigator-initiated IGIV studies in oncology, transplantation, ophthalmology, obstetrics and gynecology, and dermatology.

In order to help applicants tailor their applications appropriately, it is worth remembering that the novelty of an application is important. If the Talents Evaluation Committee believes that a proposal is re-visiting issues that are already well established in the scientific and clinical literature, its chances of receiving funding are diminished. Also, if a researcher seeks to do clinical research into new areas of IGIV use, there should be a body of literature or other compelling scientific reasons for exploring this indication. In other words, some proof of concept is needed or a researcher should first apply to conduct a basic science proof of concept study.